USP5 Stabilizes TGFBR1 to Drive Vascular Smooth Muscle Cell Senescence and Atherosclerosis
Advanced Science · 2026
DOI: 10.1002/advs.76911 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2026. Verfasst von Xinhai Cui und 5 weiteren Autor:innen. Beteiligte Einrichtung: College of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine, Jinan, China. Hauptthemen laut MEDLINE: Atherosclerosis, Cellular Senescence, Muscle, Smooth, Vascular, Receptor, Transforming Growth Factor-beta Type I. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Nature Science Foundation of China, Jinan City University-Local Integration Development Strategic Project, Special Fund for Taishan Scholar Project.
Abstract (Originalsprache)
Vascular smooth muscle cell (VSMC) senescence contributes importantly to atherosclerotic plaque progression, yet the upstream mechanisms remain incompletely understood. Here, by integrating single‐cell RNA sequencing analysis with human plaque validation, we found that TGFBR1 is enriched in senescent VSMCs in atherosclerotic lesions and correlates with senescence‐associated markers. In vivo, VSMC‐specific TGFBR1 knockin in Apoe‐deficient mice accelerated plaque development and increased VSMC senescence. Mechanistically, we identified the deubiquitinase USP5 as a previously unrecognized stabilizer of TGFBR1. USP5 directly interacted with TGFBR1 and selectively removed K48‐linked polyubiquitin chains at lysine 213, thereby preventing proteasomal degradation. Stabilized TGFBR1 suppressed the mitochondrial enzyme IDH2, driving a metabolic shift toward glycolysis that sustained apoptosis resistance in senescent VSMCs. Conversely, VSMC‐specific knockdown of USP5 reduced TGFBR1 expression, restored IDH2 expression, attenuated glycolytic remodeling, and mitigated atherosclerosis in viv o. Our findings reveal a USP5‐TGFBR1‐IDH2 axis in which site‐specific deubiquitination at K213 links receptor stability to metabolic remodeling and VSMC senescence, identifying USP5 as a potential therapeutic target for atherosclerosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine, Jinan, China.
- Innovation Research Institute of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine, Jinan, China.
- Department of Cardiovascular, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, China.
ORCID-Profile: Xinhai Cui, Chao Li, Yunlun Li
Förderung
- National Nature Science Foundation of China
- Jinan City University-Local Integration Development Strategic Project
- Special Fund for Taishan Scholar Project
- Shandong Provincial Natural Science Foundation
- China Postdoctoral Science Foundation
- Natural Science Foundation of Shandong Province
Zitieren
APA
Cui, X., Hu, Y., Lin, L., Zhang, L., Li, C., & Li, Y. (2026). USP5 Stabilizes TGFBR1 to Drive Vascular Smooth Muscle Cell Senescence and Atherosclerosis. Advanced Science. https://doi.org/10.1002/advs.76911
Vancouver
Cui X, Hu Y, Lin L, Zhang L, Li C, Li Y. USP5 Stabilizes TGFBR1 to Drive Vascular Smooth Muscle Cell Senescence and Atherosclerosis. Advanced Science. 2026. doi:10.1002/advs.76911
BibTeX
@article{Cui2026,
author = {Cui, Xinhai and Hu, Yuanlong and Lin, Lin and Zhang, Lei and Li, Chao and Li, Yunlun},
title = {USP5 Stabilizes TGFBR1 to Drive Vascular Smooth Muscle Cell Senescence and Atherosclerosis},
journal = {Advanced Science},
year = {2026},
doi = {10.1002/advs.76911}
}
EUVIMED